Newsroom
World TB Day 2024: Investing in the power of collaboration to end TB
Sunday, 24 March is World TB Day. As the largest public-private partnership in TB drug development in the history of the European Union, we’re proud to show our support!
Tuberculosis (TB) continues to be a global health challenge that demands urgent solutions. UNITE4TB understands that the key to meeting this challenge is collaboration. Together with our public & private partners and affected communities, we are exploring novel drug combinations, new drug candidates, and innovative approaches to clinical trials. Our aim is to develop better, faster treatments for people affected by TB.
With two clinical trials underway and recruitment at over 40 trial sites in 15 countries in the works, UNITE4TB is making good progress in the fight against tuberculosis.
Stakeholder perspectives on UNITE4TB
This World TB Day, we asked experts in the field to comment on the importance of investing in TB research and development. Watch our new video featuring Charles Wells of the Bill & Melinda Gates Medical Research Institute, Cherise Scott of Unitaid, and Kelly Dooley of the Vanderbilt University Medical Center.
Webinar on community engagement in TB action
With a focus on community engagement in TB treatment and care, the next UNITE4TB webinar aims to impart an understanding of the importance of community engagement in TB action, the link between civil society and TB care, and the specific challenges faced when it comes to engaging in clinical trials.
Date: Thursday, 28 March
Time: 13:00-14:00 (CET)